137 related articles for article (PubMed ID: 20550049)
1. Generics offer pharmacy plans specific benefits.
Reinke T
Manag Care; 2010 Feb; 19(2):28-30, 34. PubMed ID: 20550049
[No Abstract] [Full Text] [Related]
2. [Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts].
MMW Fortschr Med; 2008 Oct; 150(40):52-3. PubMed ID: 18990887
[No Abstract] [Full Text] [Related]
3. [Decreased need for tablets with pantoprazole. PPI: independent study questions savings through use of generic drugs].
MMW Fortschr Med; 2007 Dec; 149(49-50):58. PubMed ID: 18236985
[No Abstract] [Full Text] [Related]
4. [Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
Hashiguchi M; Yamauchi N; Uchikura T; Mochizuki M
Yakugaku Zasshi; 2008 Apr; 128(4):585-94. PubMed ID: 18379175
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of gastric acid-induced illnesses in general practice. The first pantoprazole generic drug has arrived].
MMW Fortschr Med; 2009 Jan; 151(5):46-7. PubMed ID: 19391415
[No Abstract] [Full Text] [Related]
6. AstraZeneca must pay €52.5m fine for anticompetitive tactics, rules European court.
Hawkes N
BMJ; 2012 Dec; 345():e8396. PubMed ID: 23230222
[No Abstract] [Full Text] [Related]
7. Pharmacies receiving massive rebates from generic drug-makers.
Silversides A
CMAJ; 2006 Aug; 175(4):342. PubMed ID: 16908889
[No Abstract] [Full Text] [Related]
8. Why is this woman smiling? The hard sell of bad medicine.
Bloice C
Revolution (Oakl); 2005; 6(1):22-9. PubMed ID: 15822700
[No Abstract] [Full Text] [Related]
9. OTC omeprazole for your heartburn--enormous value-for-money opportunity.
Curtiss FR
J Manag Care Pharm; 2004; 10(5):458-60. PubMed ID: 15369431
[No Abstract] [Full Text] [Related]
10. [Cheap omeprazole?].
Piqué JM
Gastroenterol Hepatol; 1998 Feb; 21(2):95-6. PubMed ID: 9549188
[No Abstract] [Full Text] [Related]
11. Biotech industry struggles with generics approval.
Knight J
Nature; 2004 Jun; 429(6992):588. PubMed ID: 15190316
[No Abstract] [Full Text] [Related]
12. Generics battle brand names over mortality of drug patents.
Betz R
J Healthc Resour Manag; 1995 Jul; 13(7):35-7. PubMed ID: 10144008
[No Abstract] [Full Text] [Related]
13. The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study.
Morreale A
Manag Care Interface; 2001; Suppl B():28-30; discussion 31-3. PubMed ID: 11569296
[No Abstract] [Full Text] [Related]
14. Best buy drugs: many common generics beat brand names.
Consum Rep; 2011 Mar; 76(3):24-7. PubMed ID: 21434454
[No Abstract] [Full Text] [Related]
15. Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.
Harris BN; West DS; Johnson J; Hong SH; Stowe CD
J Manag Care Pharm; 2004; 10(5):449-55. PubMed ID: 15369428
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor utilization patterns in infants.
Barron JJ; Tan H; Spalding J; Bakst AW; Singer J
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):421-7. PubMed ID: 18030207
[TBL] [Abstract][Full Text] [Related]
17. Health plans keeping drug cost increases in check with programs that promote generics.
Capitation Manag Rep; 2002 Jul; 9(7):101-3, 97. PubMed ID: 12164057
[TBL] [Abstract][Full Text] [Related]
18. The generics in transplantation and the rules on their use.
Masri M
Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
[TBL] [Abstract][Full Text] [Related]
19. Pfizer receives US$2.15 billion in patent damages.
Sklan A
Pharm Pat Anal; 2013 Sep; 2(5):583. PubMed ID: 24386655
[No Abstract] [Full Text] [Related]
20. Authorized generics.
Glass G
Nat Rev Drug Discov; 2005 Dec; 4(12):953-4. PubMed ID: 16370080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
